Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (102002) 102002
Newsletter (26155) 26155
Publication (12674) 12674
Newspaper Article (6252) 6252
Book Review (1225) 1225
Magazine Article (978) 978
Book Chapter (499) 499
Trade Publication Article (283) 283
Conference Proceeding (205) 205
Transcript (205) 205
Book / eBook (161) 161
Web Resource (101) 101
Dissertation (95) 95
Government Document (34) 34
Streaming Video (32) 32
Data Set (22) 22
Reference (19) 19
Paper (18) 18
Report (10) 10
Journal / eJournal (9) 9
Video Recording (3) 3
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (71101) 71101
antiviral agents (66658) 66658
index medicus (40839) 40839
antiviral agents - therapeutic use (34893) 34893
male (28718) 28718
female (28621) 28621
hiv (23352) 23352
adult (21649) 21649
antiviral agents - pharmacology (21640) 21640
animals (19687) 19687
health aspects (19113) 19113
research (19052) 19052
middle aged (18581) 18581
drug therapy (17435) 17435
virology (14490) 14490
infectious diseases (13853) 13853
aids (13733) 13733
pharmacology & pharmacy (13178) 13178
infection (13110) 13110
treatment outcome (11774) 11774
viruses (10943) 10943
analysis (10928) 10928
care and treatment (10633) 10633
virus diseases (10624) 10624
anti-hiv agents (10324) 10324
hiv infections - drug therapy (9994) 9994
hepatitis c, chronic - drug therapy (9947) 9947
antiviral agents - administration & dosage (9859) 9859
highly active antiretroviral therapy (9838) 9838
hepatitis c virus (9725) 9725
drug therapy, combination (9717) 9717
hepatitis c (9662) 9662
immunology (9584) 9584
microbiology (9523) 9523
medical research (9300) 9300
gastroenterology & hepatology (8905) 8905
hiv infection (8841) 8841
aged (8215) 8215
therapy (8180) 8180
medicine, experimental (8164) 8164
drugs (7751) 7751
infections (7509) 7509
interferon (7493) 7493
virus replication - drug effects (7439) 7439
interferon-alpha - therapeutic use (6982) 6982
mice (6971) 6971
cell line (6834) 6834
antiviral agents - adverse effects (6770) 6770
risk factors (6731) 6731
human immunodeficiency virus--hiv (6659) 6659
viral load (6256) 6256
ribavirin - therapeutic use (6162) 6162
antiviral agents - chemistry (6042) 6042
adolescent (5896) 5896
antiviral activity (5863) 5863
research article (5839) 5839
genotype (5757) 5757
hepatitis (5745) 5745
influenza (5684) 5684
ribavirin (5676) 5676
pharmaceutical industry (5647) 5647
hepatitis b (5616) 5616
hepacivirus - genetics (5378) 5378
drug resistance (5350) 5350
biochemistry & molecular biology (5336) 5336
hepatitis c - drug therapy (5312) 5312
hiv patients (5291) 5291
antiretroviral therapy (5156) 5156
replication (5132) 5132
chemistry, medicinal (5080) 5080
medicine (4973) 4973
prevention (4940) 4940
dosage and administration (4933) 4933
hiv-1 - drug effects (4843) 4843
time factors (4758) 4758
recombinant proteins (4692) 4692
universities and colleges (4646) 4646
young adult (4629) 4629
hepatitis b, chronic - drug therapy (4581) 4581
hepacivirus - drug effects (4511) 4511
in-vitro (4420) 4420
article (4399) 4399
retrospective studies (4385) 4385
medicine, general & internal (4300) 4300
human-immunodeficiency-virus (4264) 4264
antivirals (4217) 4217
mutation (4186) 4186
reports (4146) 4146
multidisciplinary sciences (4142) 4142
rna (4087) 4087
child (4006) 4006
virus (3895) 3895
usage (3862) 3862
virus-infection (3846) 3846
structure-activity relationship (3772) 3772
drug resistance, viral (3738) 3738
mortality (3721) 3721
liver (3714) 3714
anti-hiv agents - therapeutic use (3700) 3700
antiviral therapy (3679) 3679
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (96) 96
Online Resources - Online (96) 96
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
UofT at Mississauga - Stacks (8) 8
UofT at Scarborough - Stacks (6) 6
Gerstein Science - Periodical Stacks (5) 5
Gerstein Science - Bindery (3) 3
Media Commons - Audio Visual (3) 3
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Processing (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (129351) 129351
Chinese (1208) 1208
Russian (1158) 1158
French (1127) 1127
German (959) 959
Japanese (727) 727
Spanish (559) 559
Polish (267) 267
Korean (213) 213
Italian (132) 132
Hungarian (127) 127
Dutch (106) 106
Portuguese (81) 81
Danish (73) 73
Ukrainian (60) 60
Czech (55) 55
Swedish (50) 50
Croatian (38) 38
Bulgarian (34) 34
Finnish (30) 30
Romanian (30) 30
Turkish (30) 30
Norwegian (28) 28
Serbian (24) 24
Hebrew (22) 22
Arabic (8) 8
Persian (8) 8
Slovak (8) 8
Lithuanian (4) 4
Bosnian (3) 3
Icelandic (2) 2
Albanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Advances in antiviral drug design
Advances in antiviral drug design, ISSN 1075-8593, 1993
Design | Antiviral agents | Periodicals
Journal
Details down arrow
2. Full Text Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
by Signe Westring Worm and Caroline Sabin and Rainer Weber and Peter Reiss and Wafaa EI-Sadr and Francois Dabis and Stephane De Wit and Matthew Law and Antonella D'Arminio Monforte and Nina Friis-Møller and Ole Kirk and Eric Fontas and Ian Weller and Andrew Phillips and Jens Lundgren and D A D Study Grp
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2010, Volume 201, Issue 3, pp. 318 - 330
Background. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been assessed in 13 anti-HIV drugs in the... 
Myocardial infarction | HIV/AIDS | Antiretrovirals | HIV | Dyslipidemias | Antivirals | Predisposing factors | AIDS | Lipids | Anti HIV agents | Cardiovascular diseases | INFECTIOUS DISEASES | REVERSE-TRANSCRIPTASE INHIBITORS | THERAPY | NAIVE PATIENTS | INSULIN-RESISTANCE | CARDIOVASCULAR-DISEASE | RANDOMIZED-TRIAL | HIV-1-INFECTED PATIENTS | LOPINAVIR/RITONAVIR | BODY-COMPOSITION | PROTEASE INHIBITORS | Myocardial Infarction - chemically induced | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Risk Factors | Logistic Models | Male | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | Poisson Distribution | Aged | Myocardial Infarction - etiology | Antiviral agents | Complications and side effects | Research | Demographic aspects | Heart attack | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Antiviral drugs
: from basic discovery through clinical trials
by Kazmierski, Wieslaw M
2011, ISBN 9780470934685, xiii, 438 p., [16] p. of plates
This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the... 
Antiviral agents
Book
Details down arrow
4. ANTIVIRAL DRUGS
by DRISCOLL, JOHN S
2002, ISBN 9780566083105
Book
Details down arrow
5. Antiviral drugs
: basic and therapeutic aspects
by Caliò, R and Nisticò, Giuseppe
1989, ISBN 8882852033, x, 220
Virus diseases | Antiviral agents | Chemotherapy
Book
Details down arrow
6. Full Text Antiretroviral resistance in clinical practice
by Geretti, Anna Maria, 1962
2006, ISBN 9780955166907
HIV Infections | Clinical Medicine | Chemotherapy | drug therapy | Antiretroviral agents | Drug Resistance, Viral | AIDS (Disease) | Anti-Retroviral Agents
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antiretroviral drugs
by De Clercq, Erik
Current Opinion in Pharmacology, ISSN 1471-4892, 2010, Volume 10, Issue 5, pp. 507 - 515
In October 2010, it will be exactly 25 years ago that the first antiretroviral drug, AZT (zidovudine, 3′-azido-2′,3′-dideoxythymidine), was described. It was... 
Internal Medicine | Medical Education | RESISTANT HIV-1 INFECTION | REVERSE-TRANSCRIPTASE INHIBITORS | VIRUS | COMBINATION THERAPY | INVITRO | IN-VIVO | RALTEGRAVIR RESISTANCE | PHARMACOLOGY & PHARMACY | MUTATIONS | TREATMENT-NAIVE PATIENTS | DISCOVERY | Anti-HIV Agents - classification | Antiretroviral Therapy, Highly Active | Anti-HIV Agents - history | History, 21st Century | HIV Infections - history | History, 20th Century | Humans | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | DNA polymerases | Highly active antiretroviral therapy | Antiviral agents | Protease inhibitors | Proteases | Anti-HIV agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
by Günthard, Huldrych F and Saag, Michael S and Benson, Constance A and del Rio, Carlos and Eron, Joseph J and Gallant, Joel E and Hoy, Jennifer F and Mugavero, Michael J and Sax, Paul E and Thompson, Melanie A and Gandhi, Rajesh T and Landovitz, Raphael J and Smith, Davey M and Jacobsen, Donna M and Volberding, Paul A
JAMA, ISSN 0098-7484, 07/2016, Volume 316, Issue 2, pp. 191 - 210
IMPORTANCE: New data and therapeutic options warrant updated recommendations for the use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in... 
LOW-LEVEL VIREMIA | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | VIROLOGICALLY SUPPRESSED ADULTS | TWICE-DAILY RALTEGRAVIR | REVERSE-TRANSCRIPTASE INHIBITORS | ONCE-DAILY DOLUTEGRAVIR | RITONAVIR PLUS LAMIVUDINE | COGNITIVE-BEHAVIORAL THERAPY | DEPRESSION CBT-AD | BOOSTED PROTEASE INHIBITOR | HIV-1 | HIV Infections - prevention & control | AIDS-Related Opportunistic Infections | Anti-Retroviral Agents - therapeutic use | Prognosis | Viremia | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Viral Load | Pre-Exposure Prophylaxis | Pregnancy | Young Adult | Treatment Failure | Adolescent | Post-Exposure Prophylaxis | Adult | Female | HIV Infections - drug therapy | Aged | Drug Therapy, Combination | Prevention | Antiviral agents | Care and treatment | Dosage and administration | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Antiviral drugs
: from basic discovery through clinical trials
by Kazmierski, Wieslaw M
2011, ISBN 9780470934685
Antiviral agents | Drug Evaluation | Clinical Trials as Topic | Drug Discovery | therapeutic use
Web Resource
Details down arrow
10. Full Text Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2017
by Yu, JJ and Petrie, ID and Levy, RH and Ragueneau-Majlessi, I
DRUG METABOLISM AND DISPOSITION, ISSN 0090-9556, 02/2019, Volume 47, Issue 2, pp. 135 - 144
Pharmacokinetic-based drug-drug interaction (DDI) data for drugs approved by the U.S. Food and Drug Administration in 2017 (N = 34) were analyzed using the... 
KETOCONAZOLE | PHARMACOLOGY & PHARMACY | FDA | Drugs | Enzymes | Antiviral agents | Drug interactions | Substrate inhibition | Data processing | Labels | Breast cancer | Pharmacology | FDA approval | Substrates | Proteins | Organic anion transporting polypeptide | Inhibitors | Drug interaction | Cancer | Food
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. LIFE SAVING DRUGS: THE ELUSIVE MAGIC BULLET
by MANN, JOHN
2004, RSC PAPERBACKS., ISBN 0854046348, 257
In 1900 only a handful of drugs (morphine, quinine, aspirin, etc) had genuine efficacy but had little value for bacterial or viral infections or cancer. These... 
Science | General | Chemistry | Higher | Education | Anime | Japón | Dibujos animados | Comic books, strips, etc | Japon | Libros electronicos | Animated films | Manga | Historietas | Drugs | Pharmacology
Book
Details down arrow
12. Antiviral drug discovery for emerging diseases and bioterrorism threats
by Torrence, Paul F
2005, ISBN 9780471668275, x, 420
Antiviral agents | Drug development | Bioterrorism | Emerging infectious diseases
Book
Details down arrow
13. Full Text Inhibition of polyamine biosynthesis is a broad-spectrum strategy against RNA viruses
by Mounce, Bryan C and Cesaro, Teresa and Moratorio, Gonzalo and Hooikaas, Peter Jan and Yakovleva, Anna and Werneke, Scott W and Smith, Everett Clinton and Poirier, Enzo Z and Simon-Loriere, Etienne and Prot, Matthieu and Tamietti, Carole and Vitry, Sandrine and Volle, Romain and Khou, Cécile and Frenkiel, Marie-Pascale and Sakuntabhai, Anavaj and Delpeyroux, Francis and Pardigon, Nathalie and Flamand, Marie and Barba-Spaeth, Giovanna and Lafon, Monique and Denison, Mark R and Albert, Matthew L and Vignuzzi, Marco
Journal of Virology, ISSN 0022-538X, 2016, Volume 90, Issue 21, pp. 9683 - 9692
RNA viruses present an extraordinary threat to human health, given their sudden and unpredictable appearance, the potential for rapid spread among the human... 
DRUG | EFLORNITHINE | REPLICATION | VIROLOGY | ALPHA-DIFLUOROMETHYLORNITHINE | DEPLETION | INFECTION | TRANSLATION | MAMMALIAN-CELLS | RESPIRATORY SYNDROME CORONAVIRUS | SPERMIDINE | Zika Virus Infection - drug therapy | Acetyltransferases - metabolism | Ebolavirus - metabolism | Chikungunya virus - metabolism | Humans | Eflornithine - pharmacology | Ebolavirus - drug effects | Zika Virus Infection - virology | Disease Outbreaks | RNA Viruses - drug effects | Hemorrhagic Fever, Ebola - virology | Hemorrhagic Fever, Ebola - drug therapy | Spermine - analogs & derivatives | Cell Line | Virus Replication - drug effects | Antiviral Agents - pharmacology | Mice, Inbred C57BL | Chikungunya Fever - drug therapy | Zika Virus - drug effects | Chikungunya Fever - virology | Polyamines - metabolism | Chikungunya virus - drug effects | Animals | Spermine - pharmacology | Mice | Spermine/analogs & derivatives | Virus Replication/drug effects | Hemorrhagic Fever, Ebola/virology | Life Sciences | Zika Virus/drug effects | Immunology | Chikungunya virus/metabolism | Chikungunya Fever/drug therapy | Zika Virus Infection/drug therapy | Ebolavirus/drug effects | Acetyltransferases/metabolism | Chikungunya virus/drug effects | Eflornithine/pharmacology | Spermine/pharmacology | Polyamines/metabolism | Chikungunya Fever/virology | Hemorrhagic Fever, Ebola/drug therapy | Virology | Microbiology and Parasitology | Zika Virus Infection/virology | Ebolavirus/metabolism | Antiviral Agents/pharmacology | RNA Viruses/drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text New hepatitis C virus therapies: drug classes and metabolism, drug interactions relevant in the transplant settings, drug options in decompensated cirrhosis, and drug options in end-stage renal disease
by Kwo, Paul Y and Badshah, Maaz B
Current opinion in organ transplantation, ISSN 1087-2418, 06/2015, Volume 20, Issue 3, pp. 235 - 241
Purpose of review This article will review the new direct acting antiviral agent (DAA) drug classes for the treatment of hepatitis C, how they are combined and... 
hepatitis C | SOFOSBUVIR | POLYMERASE | SIMEPREVIR | end-stage renal disease | COMBINATION | liver cirrhosis | TRANSPLANTATION | NS5A INHIBITOR | REPLICATION | decompensated cirrhosis | ANTIVIRAL ACTIVITY | BOCEPREVIR | HCV | liver transplant | direct acting antiviral agents | EPIDEMIOLOGY | Liver Cirrhosis - etiology | Liver Transplantation | Drug Interactions | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Kidney Failure, Chronic - complications | Hepatitis C - complications | Antiviral Agents - metabolism | Hepacivirus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel
by Saag, Michael S and Benson, Constance A and Gandhi, Rajesh T and Hoy, Jennifer F and Landovitz, Raphael J and Mugavero, Michael J and Sax, Paul E and Smith, Davey M and Thompson, Melanie A and Buchbinder, Susan P and Del Rio, Carlos and Eron, Joseph J and Fätkenheuer, Gerd and Günthard, Huldrych F and Molina, Jean-Michel and Jacobsen, Donna M and Volberding, Paul A
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 07/2018, Volume 320, Issue 4, pp. 379 - 396
IMPORTANCE Antiretroviral therapy (ART) is the cornerstone of prevention and management of HIV infection. OBJECTIVE To evaluate new data and treatments and... 
MULTIDRUG-RESISTANT HIV-1 | NON-INFERIORITY | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | VIROLOGICALLY SUPPRESSED ADULTS | COST-EFFECTIVENESS | DEMAND PREEXPOSURE PROPHYLAXIS | ATAZANAVIR/RITONAVIR PLUS LAMIVUDINE | DOUBLE-BLIND | HUMAN-IMMUNODEFICIENCY-VIRUS | CD4 CELL COUNT | HIV Infections - prevention & control | Anti-Retroviral Agents - therapeutic use | Diagnosis, Differential | Time-to-Treatment | HIV Infections - diagnosis | Humans | Adult | HIV Infections - drug therapy | Fees, Pharmaceutical | Advisory Committees | Prevention | Antiviral agents | Treatment outcome | Analysis | Adults | Dosage and administration | Drug therapy | Health aspects | HIV infection | Drugs | Therapy | RNA-directed DNA polymerase | Prophylaxis | Medical services | Risk | Infections | Drug resistance | Tenofovir | Literature reviews | Sexually transmitted diseases | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Genotypes | Monitoring | Integrase | Emtricitabine | Antiretroviral drugs | Medical treatment | Health risks | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Disease prevention | Pregnancy | Laboratory tests | Risk management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
by Xu, Miao and Lee, Emily M and Wen, Zhexing and Cheng, Yichen and Huang, Wei-Kai and Qian, Xuyu and Tcw, Julia and Kouznetsova, Jennifer and Ogden, Sarah C and Hammack, Christy and Jacob, Fadi and Nguyen, Ha Nam and Itkin, Misha and Hanna, Catherine and Shinn, Paul and Allen, Chase and Michael, Samuel G and Simeonov, Anton and Huang, Wenwei and Christian, Kimberly M and Goate, Alison and Brennand, Kristen J and Huang, Ruili and Xia, Menghang and Ming, Guo-Li and Zheng, Wei and Song, Hongjun and Tang, Hengli
Nature Medicine, ISSN 1078-8956, 10/2016, Volume 22, Issue 10, pp. 1101 - 1107
In response to the current global health emergency posed by the Zika virus (ZIKV) outbreak and its link to microcephaly and other neurological conditions, we... 
MEDICINE, RESEARCH & EXPERIMENTAL | REPLICATION | THERAPY | CDK9 INHIBITORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOLOGY | MODEL | SEXUAL TRANSMISSION | ORGANOIDS | CELL BIOLOGY | Astrocytes - drug effects | Cell Line | Virus Replication - drug effects | Zika Virus Infection - drug therapy | Caspase Inhibitors - pharmacology | Induced Pluripotent Stem Cells - drug effects | Humans | Neural Stem Cells - drug effects | Zika Virus - drug effects | Drug Repositioning | Brain - drug effects | Organoids | Niclosamide - pharmacology | Caspase 3 - drug effects | Microcephaly - prevention & control | Pentanoic Acids - pharmacology | Cell Death - drug effects | Neurons - drug effects | Antiviral agents | Dosage and administration | Research | Cell death | Testing | Neuroprotection | Emergency response | Niclosamide | Viruses | Outbreaks | Infections | Zika virus | Drug development | Kinases | Caspase-3 | Caspase inhibitors | Inhibition | Public health | Vector-borne diseases | Astrocytes | Cortex | Pharmacology | FDA approval | Lead compounds | Microencephaly | Inhibitors | Neural stem cells | Replication | Apoptosis | microcephaly | cortical neural progenitor | high-throughput screening | cyclin-dependent kinase inhibitors | astrocyte | drug repurposing screen | caspase-3
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights